VitaNav Inc.
D-beta hydroxybutyrate (D-BHB) ketone body compounds for energy and neurohealth
- Sector
- Biotech
- Headquarters
- HALETHORPE, MD
- Latest Form D
- $1.2M, Feb 2026
- Total capital
- $10.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $10.7M
- 3 Form D · last Feb 2026
- 8 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 6 pending · first 2021
- Rank in peer group#293 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$1.2M
- Private capital raisedForm D · SEC · 2nd filing$6.3M
- Private capital raisedForm D · SEC · 1st filing$3.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#293 · top 20%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Price DevonResearcherExecutive Officer, DirectorLinked by 4 patents
- Albert BaladiDirectorNamed in SEC Form D filings
- Clifford MorganExecutive Officer, DirectorNamed in SEC Form D filings
- Cynthia TsaiDirectorNamed in SEC Form D filings
- Eduardo BrondiDirectorNamed in SEC Form D filings
- Peter BayneExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 10- PendingMethod Of Improving Flavor Of A Composition Of (d)-beta-hydroxybutyric Acid And (D)-1,3 Butanediol And Use As A Nutritional Supplement And Therapeutic AgentUSPTOApplication 19343793
- GrantedMethod Of Improving Flavor Of A Composition Of (d)-beta-hydroxybutyric Acid And (D)-1,3 Butanediol And Use As A Nutritional Supplement And Therapeutic AgentUSPTOUS 12,439,945
- PendingMethods To Produce Therapeutic Formulations Comprising Hydroxybutirate And Hydroxyvalerate, Therapeutic Formulations And Uses ThereofUSPTOApplication 18574355
Show all 10 patent records
- Method Of Improving Flavor Of A Composition Of (d)-beta-hydroxybutyric Acid And (D)-1,3 Butanediol And Use As A Nutritional Supplement And Therapeutic AgentFeb 19, 2026 · Application 19343793Pending
- Method Of Improving Flavor Of A Composition Of (d)-beta-hydroxybutyric Acid And (D)-1,3 Butanediol And Use As A Nutritional Supplement And Therapeutic AgentOct 14, 2025 · US 12,439,945Granted
- Methods To Produce Therapeutic Formulations Comprising Hydroxybutirate And Hydroxyvalerate, Therapeutic Formulations And Uses ThereofNov 7, 2024 · Application 18574355Pending
- Method Of Improving Flavor Of A Composition Of (d)-beta-hydroxybutyric Acid And (D)-1,3 Butanediol And Use As A Nutritional Supplement And Therapeutic AgentMay 21, 2024 · US 11,985,999Granted
- COMPOSITION OF (D)-ß-HYDROXYBUTYRIC ACID, (D)-1,3 BUTANEDIOL AND DIGESTIBLE CARBOHYDRATEMar 16, 2023 · Application 18050344Pending
- COMPOSITION OF (D)-Beta-HYDROXYBUTYRIC ACID, (D)-Beta-HYDROXYVALERIC ACID, AND (D)-1,3 BUTANEDIOLOct 21, 2021 · Application 17360205Pending
- Method Of Improving Flavor Of A Composition Of (d)-beta-hydroxybutyric Acid And (D)-1,3 Butanediol And Use As A Nutritional Supplement And Therapeutic AgentOct 12, 2021 · US 11,141,392Granted
- COMPOSITION OF (D)-Beta-HYDROXYBUTYRIC ACID, (D)-Beta-HYDROXYVALERIC ACID, AND (D)-1,3 BUTANEDIOLJun 29, 2021 · US 11,044,932Granted
- Methods To Produce Therapeutic Formulation Components, Therapeutic Formulations And Uses ThereofApplication PCTUS2022034675Pending
- Methods To Produce Therapeutic Formulation Components, Therapeutic Formulations And Uses ThereofApplication 63215711Pending
Related companies, and why
- Gut-Brain-Axis Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- IMMUTEP LtdSimilar federal contract value in Biotech · null in contracts
- Fauna Systems Inc.Similar federal contract value in Biotech · null in contracts
- Topo Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- SG Vector Holdings, LLCSimilar federal contract value in Biotech · null in contracts
- EXCELIMMUNE, INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .